Fosun International LTD Amgen Inc Transaction History

Fosun International LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $238,803 - $279,787	-1,125 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$221.91 - $258.6 $100,969 - $117,663	-455 Reduced 28.8%	1,125 $281,000
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $312,539 - $383,529	1,580 New	1,580 $366,000
Q1 2020 May 11, 2020	SELL	$182.24 - $241.7 $189,529 - $251,368	-1,040 Closed	0 $0
Q4 2019 Feb 18, 2020	BUY	$189.21 - $243.2 $196,778 - $252,928	1,040 New	1,040 $251,000
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $579,786 - $694,704	-3,330 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $90,018 - $105,521	-540 Reduced 13.95%	3,330 $613,000
Q1 2019 May 10, 2019	BUY	$180.87 - $203.88 $97,669 - $110,095	540 Added 16.22%	3,870 $726,000
Q3 2018 Nov 09, 2018	BUY	$185.29 - $208.89 $617,015 - $695,603	3,330 New	3,330 $696,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.